Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Security class unavailable · CUSIP: 00773U207

Event date: 2024-10-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,116,628
Percent of class
5.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002042778-24-000002
Form type
SC 13G
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Oct 30, 2024
Reporting period
Oct 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub